Equities

Medmen Enterprises Inc

Medmen Enterprises Inc

Actions
  • Price (EUR)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-10.00%
  • Beta--
Data delayed at least 15 minutes, as of Jan 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty program, provides access to promotions, product drops and content. It produces and curates the consumer product assortment for retail operations in its local communities with services and engaging in-store experience, combined with reward, delivery, and e-commerce programs. It also offers buds rewards, where buds members earn points with every purchase, plus exclusive access to drops and deals. The Company also provides gift cards.

  • Revenue in CAD (TTM)165.02m
  • Net income in CAD-196.88m
  • Incorporated1987
  • Employees702.00
  • Location
    Medmen Enterprises Inc8740 S. SEPULVEDA BOULEVARD, SUITE 105LOS ANGELES 90045United StatesUSA
  • Phone+1 (424) 330-2082
  • Fax+1 (604) 270-4620
  • Websitehttps://medmen.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.